4 assets in Kennedy Disease

Therapeutic assets addressing Kennedy Disease, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Mexiletine Kennedy Disease	Masahisa Katsuno	P2/3	B (57)
Nido-361 Kennedy Disease	Nido Biosciences, Inc.	P2	B (57)
Clenbuterol Kennedy Disease	Gianni Soraru	P2	CCC (53)
aj201 Kennedy Disease	AnnJi Pharmaceutical Co., Ltd.	P1/2	CCC (52)